When can we expect the commercial availability of a dengue vaccine by mid-2026
Anticipating the timeline for the commercial release of a vaccine for dengue in the market by mid-2026.
Based on the typical timeline for vaccine development and regulatory approvals, the commercial availability of a dengue vaccine by mid-2026 may follow these general points:
- 1. Vaccine Development: Research, development, and testing of the vaccine may take several years to ensure safety and efficacy.
- 2. Clinical Trials: Trials involving different phases, including testing on thousands of participants to evaluate effectiveness and safety.
- 3. Regulatory Approval: Submission of data to regulatory authorities for review and approval, which can take additional time for assessment.
- 4. Manufacturing Scale-up: Once approved, production facilities need to scale up manufacturing to meet global demand.
- 5. Distribution: Distribution logistics must be arranged to ensure widespread availability.
Answered
a year ago